Unique ID issued by UMIN | UMIN000039649 |
---|---|
Receipt number | R000045222 |
Scientific Title | effect of combined aerobic-resistance training on Adropin levels and arterial stiffness in women with type 2 diabetes mellituse |
Date of disclosure of the study information | 2020/03/01 |
Last modified on | 2023/11/07 17:16:47 |
effect of combined aerobic-resistance training in women with type 2 diabetes mellituse.
effect of combined aerobic-resistance training in women with type 2 diabetes mellituse
effect of combined aerobic-resistance training on Adropin levels and arterial stiffness in women with type 2 diabetes mellituse
effect of combined aerobic-resistance training on Adropin levels and arterial stiffness in women with type 2 diabetes mellituse
Asia(except Japan) |
women diabetic type2.
Psychiatry | Rehabilitation medicine |
Others
NO
1)Effect of combined aerobic-resistance training on Adropin in women with type 2 diabetes mellituse.
2)Effect of combined aerobic-resistance training on Blood sugar levels in women with type 2 diabetes mellituse.
3)Effect of combined aerobic-resistance training on Body fat percentage in women with type 2 diabetes mellituse.
4)Effect of combined aerobic-resistance training on waist-Hip Ratio in women with type 2 diabetes mellituse.
5)Effect of combined aerobic-resistance training on cardio-ankle vascular index (CAVI) in women with type 2 diabetes mellituse.
6)Effect of combined aerobic-resistance training on systole in women diabetic type2 .
7)Effect of combined aerobic-resistance training on diastole in women diabetic type2.
8)Effect of combined aerobic-resistance training on Insulinin women with type 2 diabetes mellituse.
9)Effect of combined aerobic-resistance training on HOMA-IR in women with type 2 diabetes mellituse.
Efficacy
Adropin.(pree test and post test)
arterial stiffness.(pree test and post test)
Body fat percentage (pree test and post test)
waist-Hip Ratio. (pree test and post test)
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
2
Prevention
Other |
The experimental group will perform Moderate-intensity combined training (50-70% of maximal heart rate reserve (HRR) and 50-70% of a maximal repetition (1RM)) will be performed three times a week for 12 weeks and 60 minutes per session. Exercise intensity is controlled using the Borg scale and heart rate control at the beginning, middle and end of the exercise with verbal coach feedback, as well as by determining the weights for each intensity of 1RM. Each session consists of 15 minutes of warm-up, 20 minutes of aerobic exercise (walking and running on the treadmill) and resistance training (full body exercises including: upper chest press, shoulder press, lat pull down, leg press, bicep machine curl , tricep extension, steated leg extension, hamstring curl, situps ) are circular, 12 repetitions, 3 rounds, with a 2-3 minute break between rounds and 10 minutes of stretching exercises to cool down.
The experimental group will perform Moderate-intensity combined training (50-70% of maximal heart rate reserve (HRR) and 50-70% of a maximal repetition (1RM)) will be performed three times a week for 12 weeks and 60 minutes per session. Exercise intensity is controlled using the Borg scale and heart rate control at the beginning, middle and end of the exercise with verbal coach feedback, as well as by determining the weights for each intensity of 1RM. Each session consists of 15 minutes of warm-up, 20 minutes of aerobic exercise (walking and running on the treadmill) and resistance training (full body exercises including: upper chest press, shoulder press, lat pull down, leg press, bicep machine curl , tricep extension, steated leg extension, hamstring curl, situps ) are circular, 12 repetitions, 3 rounds, with a 2-3 minute break between rounds and 10 minutes of stretching exercises to cool down.
50 | years-old | <= |
75 | years-old | >= |
Female
1)BMI>25
2)Menopause
3)No skeletal disease
4)History of diabetes at least 4 years
5)Maximum blood pressure 160 /95 mmHg
6)Age range up to 75 years
7)Fasting blood sugar at least 126
8)Use of blood sugar control medications
9)Lack of metabolic conditions other than type2 diabetes
10)A sedentary lifestyle for at least 6 months.
1)Insulin therapy
2)Infectious diseases
3)Having skeletal diseases
4)3 sessions of obsenteeism
5)Metabolic conditions Except type2 diabetes
32
1st name | fatemeh |
Middle name | |
Last name | Mohajer Esterabadi |
Shahrood University Of Technology
Sport Physiology
3619995161
Shahrood Haft Tir Square
00989117002987
fatemeh.mohajer@shahroodut.ac.ir
1st name | fatemeh |
Middle name | |
Last name | Mohajer Esterabadi |
Shahrood University Of Technology
Sport Physiology
3619995161
Shahrood Haft Tir Square
00989117002987
fatemeh.mohajer@shahroodut.ac.ir
Shahrood University Of Technology
Shahrood University Of Technology
Self funding
Shahrood University Of Technology
Shahrood Haft Tir Square
00989117002987
fatemeh.mohajer@shahroodut.ac.ir
NO
2020 | Year | 03 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2020 | Year | 03 | Month | 03 | Day |
2019 | Year | 12 | Month | 07 | Day |
2020 | Year | 03 | Month | 10 | Day |
2020 | Year | 07 | Month | 14 | Day |
2020 | Year | 02 | Month | 29 | Day |
2023 | Year | 11 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045222
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |